MediWound (NASDAQ:MDWD) executives said 2025 marked a “pivotal year” for the company, highlighting progress in its late-stage EscharEx chronic wound program and the completion of an expanded ...
Introduction Intensive care unit (ICU) visiting restrictions in hospitals, implemented due to infection control and other factors, limited contact between patients and family members, affecting ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
In paediatrics, “more trials have been done over the last ten years, but we have struggled with transparency and clarity, and sometimes with the quality because they are not always asking the ...
We read the study conducted by Drews et al 1 with great interest. In this prospective randomised controlled trial of patients undergoing hot-snare EMR of flat lesions in the duodenum (≥10 mm) and ...
Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Amyotrophic Lateral Sclerosis Therapeutics Market size & share revenue was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results